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Fig. 1. Clusters of dendritic cells (DCs) treated with β-glucan. 
DCs were seeded at a density of 5 × 10
5 cells/mL in 6-well culture
plates, and then treated with β-glucan for 2 days. (A) DC 
morphology. ×200. (B) The number and size of DCs was 
measured by flow cytometric analysis.
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  We investigated the immunostimulatory effects of a novel 
β-glucan purified from Paenibacillus (P.) polymyxa JB115 
on bone marrow-derived dendritic cells (DCs), a type of 
potent antigen-presenting cells. β-glucan isolated from P. 
polymyxa  JB115  enhanced  the  viability  and  induced  the 
maturation of DCs. β-glucan markedly increased the cytokine 
production of DCs and surface expression of DC markers. 
In addition, DCs treated with β-glucan showed a higher 
capacity  to  stimulate  allogeneic  spleen  cell  proliferation 
compared  to  those  treated  with  medium  alone.  These 
results demonstrate the effect of β-glucan on DC maturation 
and may increase the use of β-glucan.
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β-glucans are heterogeneous glucose polymers that form 
a structural extracellular matrix in pathogenic microbes 
[1]. These compounds are recognized by several receptors 
on the surface of immune cells [4]. Recent studies 
demonstrated that a novel β-glucan purified from 
Paenibacillus (P.) polymyxa JB115 [8] induces macrophage 
activation [2].
Dendritic cells (DCs) are the most potent antigen- 
presenting cells in the immune system [12]. They are 
specialized for capturing and processing antigens, then 
presenting antigenic peptides to naïve T lymphocytes to 
initiate antigen-specific immune responses [13]. However, 
the biological effects of β-glucan purified from P. 
polymyxa JB115 on DCs remain unclear. In the present 
study, we evaluated the various biological effects of 
β-glucan on DCs.
To investigate the effects of β-glucan purified from P. 
polymyxa JB115 on DCs, we prepared immature DCs from 
bone marrow as previously described [10], and treated 
these cells with 1∼100 μg/mL β-glucan. Two days after 
β-glucan treatment, clusters of DCs were observed using 
an inverted microscope connected to a digital camera (Fig. 
1A). In addition, cell size was analyzed using flow 
cytometry. It was found that β-glucan enhanced the 
percentage of normal-sized DCs in the forward scatter/side 
scatter dot plot (Fig. 1B). A cell viability assay using a 
trypan blue solution demonstrated that 100 μg/mL 
β-glucan significantly increased the viability of DCs (Fig. 
2). Thus, β-glucan may enhance the survival of DCs and 
also helps maintain normal cell size.188    Eun-Ju Ko et al.
Fig. 3. β-glucan increases cytokine and nitric oxide production of
DCs. DCs were seeded and treated as described in Fig. 2. The 
amounts of interleukin (IL)-12 (A), tumor necrosis factor 
(TNF)-α (B), and nitric oxide (C) produced by DCs were 
measured. Data are presented as the mean ± SD from four 
individual wells. **p ＜ 0.01, ***p ＜ 0.001.
Fig. 4. β-glucan enhances the expression of immune-related DC surface markers but decreases DC antigen uptake. DCs were prepared
and treated as described in the legend for Fig. 1. For surface marker analysis (A), the number in the histogram indicates the mean 
fluorescence intensity (MFI) of the main DC population. For antigen uptake analysis (B), DCs were incubated with 250 μg/mL 
dextran-fluorescein isothiocyanate at 4
oC or 37
oC for 45 min. The number in the histogram indicates the MFI of viable DCs.
Fig. 2. Effect of β-glucan on DC viability. DCs were seeded at a 
concentration of 2.5 × 10
5 cells/mL in 96-well culture plates, and
then treated with the indicated concentrations of β-glucan for 2 
days. For the viability assay, treated cells were stained with a 
trypan blue staining solution to determine the number of live and
dead cells. Data are presented as the mean ± SD from four 
individual wells. **p ＜ 0.01.
　The production of tumor necrosis factor (TNF)-α and 
interleukin (IL)-12 by DCs treated with β-glucan was 
determined by an ELISA. IL-12 and TNF-α are 
representative cytokines involved in cell-mediated and 
innate immunity, respectively, along with DC survival 
[3,5]. β-glucan (100 μg/mL) significantly increased the 
production of both cytokines (Figs. 3A and B). In addition, 
β-glucan enhanced the release of nitric oxide from DCs 
(Fig. 3C). Nitric oxide plays a critical role in eliminating 
intracellular pathogens in macrophages.
To determine whether β-glucan induces the maturation of DC maturation by β-glucan    189
Fig. 5. β-glucan increases the allo-proliferative capability of 
DCs. DC cultures were established and treated as described in the
legend for Fig. 1. For the allo-proliferation assay, DCs treated 
with β-glucan (1 × 10
4 cells/well) were co-cultured for 5 days 
with allogeneic splenocytes (2 × 10
5 cells/well) stained with 5 
μM carboxyfluorescein succinimidyl ester. The number 
indicates the percentage of proliferating cells with a low FL1 
value in the co-culture.
DCs, expression levels of immune-related DC surface 
markers were measured by flow cytometric analysis [9]. 
Major histocompatibility complex (MHC) class I and II are 
major antigen-presenting molecules on DCs while CD54 
and CD86 are adhesion and co-stimulatory molecules, 
respectively [11]. β-glucan consistently enhanced the 
expression all of the surface markers investigated in the 
present study (Fig. 4A). Because MHC class II and CD86 
molecules have been identified as maturation markers of 
bone marrow-derived DCs [6,12], β-glucan may induce 
the maturation of DCs. Decreased antigen uptake is a major 
characteristic of mature DCs. Antigen uptake analysis 
using dextran-fluorescein isothiocyanate revealed that 
β-glucan profoundly decreased the antigen uptake capability 
of DCs compared to immature DCs (Fig. 4B). Zymosan 
was used as a positive control in this assay.
To confirm the antigen-presenting capability of DCs 
treated with β-glucan, we prepared allogeneic splenocytes 
from BALB/c mice [7]. The cells were then stained with 
carboxyfluorescein succinimidyl ester (CFSE) and co- 
cultured with immature or β-glucan-treated DCs. Highly 
proliferative cells had a relatively low CFSE intensity 
detected as FL1 by flow cytometric analysis because of 
their high cell division rates. Splenocytes cocultured with 
DCs treated with β-glucan (100 μg/mL) showed the lowest 
CFSE intensity, indicating that these cells had the highest 
proliferative capacity (Fig. 5). These observations showed 
that β-glucan enhances the antigen-presenting capability 
of DCs. Taken together, our results demonstrated that 
β-glucan from P. polymyxa JB115 induces the maturation 
of DCs, the most potent antigen-presenting cells in host 
immunity. This study may provide researchers with 
valuable information to increase the use of β-glucan. 
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